Liquid Biopsy - TLDx
NGS DNA panel - non invasive

591 genes NGS non invasive DNA panel, focused on key tumor-associated mutations for a fast and accurate tumor profiling from plasma cell-free DNA (cfDNA)

This panel is designed to provide clinical decision support for patients with solid tumor and is focused on the identification of oncologic mutations

+600 cancer-relevant genomic regions screened including

Frequently mutated genes such as BRAF, KRAS, EGFR, PIK3CA, HER2 and TP53.
SNPs detection: Single Nucleotide Polymorphisms
InDels detection: Insertions and Deletions
CNVs detection: Copy Number Variations
Gene fusions detection between covered genes plus 22 additional cancer-specific gene fusions
TMB: Determination of Tumor Mutational Burden status
‍

Order now